Clinical Research: Phase 1 - Phase 4

Phase 1 Trials: Strategies for Site Selection and Dose-Escalation


Designing and executing an effective Phase 1 trial for a novel investigational oncology product can be challenging. Every facet of the process, from site selection and recruitment rate analysis to trial design and start-up, is interconnected. A nuanced approach is important, and early, careful planning is critical.

This white paper explores key considerations for site selection and dose-escalation design strategies in early-phase oncology trials. We provide insight into how to navigate regulatory and statistical challenges to keep these trials moving forward as quickly and safely as possible.

To read more, download the complete white paper by submitting the form on this page.